FDA grants Ipca application approval for nausea medication

Alaric DeArment

6/19/2008

MUMBAI, India The Food and Drug Administration has granted approval for the Ipca Laboratories’ application for metoclopramide tablets, Ipca announced Tuesday.

Metoclopramide, which Ipca will manufacture in 5 mg and 10 mg tablets, is used to treat nausea from surgical operations and chemotherapy. Ipca will manufacture the tablets, while Ranbaxy will market them.

Several companies manufacture and market metoclopramide under a variety of brand names.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Sycamore Partners reportedly working on financing to acquire Walgreens

A potential buyout reportedly would include terms loans, a bridge loan and asset-based lending.

Ulta Beauty sets date for experiential beauty event

Ulta Beauty World will take place on April 26 in San Antonio, Texas.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.

Walgreens reportedly close to roughly $10B deal to go private

The deal could be finalized by Thursday, per a WSJ report.